Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27816552 | 0.90 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL28292332 | 0.88 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL1006495 | 0.87 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL11298865 | 0.85 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL27902459 | 0.84 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1TDP1TSHR | |
| SCHEMBL27920166 | 0.84 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1TDP1TSHR | |
| SCHEMBL16908704 | 0.84 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL1469102 | 0.82 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1TDP1TSHRPDK1 | |
| SCHEMBL5598454 | 0.78 | SMN1; SMN2 (0.49) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 | |
| SCHEMBL27836060 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110051886-A | The medical device and method that antithrombotic generates | 柯惠有限合伙公司 | 2019-07-26 | — | — | CN | claimed |
| EP-2233511-B1 | NOVEL POLYMER PARTICLE AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2017-03-22 | — | — | EP | disclosed |
| US-9150422-B2 | Porous metal oxide, method for producing the same, and use of the same | MITSUI CHEMICALS, INC. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20150152322-A1 | POLYMER PARTICLES AND USE THEREOF | MITSUI CHEMICALS, INC. (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2871216-A1 | POLYMER PARTICLES AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2015-05-13 | — | — | EP | disclosed |
| EP-2407427-A1 | NOVEL POROUS METAL OXIDE, PROCESS FOR PRODUCING SAME, AND USE OF SAME | Mitsui Chemicals, Inc. (JP) | 2012-01-18 | — | — | EP | disclosed |
| US-20110318249-A1 | NOVEL POROUS METAL OXIDE, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110118361-A1 | NOVEL POLYMER PARTICLES AND USE THEREOF | MITSUI CHEMICALS, INC. (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110033716-A1 | GAS-BARRIER COMPOSITION, COATING FILM, PROCESS FOR PRODUCING THE SAME, AND LAYERED MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-7879947-B2 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2011-02-01 | — | — | US | disclosed |
| EP-2277954-A1 | GAS BARRIER COMPOSITION, COATING FILM, METHOD FOR PRODUCING THE GAS BARRIER COMPOSITION, METHOD FOR PRODUCING THE COATING FILM, AND MULTILAYER BODY | Mitsui Chemicals, Inc. (JP) | 2011-01-26 | — | — | EP | disclosed |
| EP-2233511-A1 | NOVEL POLYMER PARTICLE AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20090171003-A1 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-7524900-B2 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2009-04-28 | — | — | US | disclosed |
| EP-1894971-A1 | GAS BARRIER COMPOSITION, COATING FILM, METHODS FOR PRODUCING THOSE, AND MULTILAYER BODY | Mitsui Chemicals, Inc. (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-20060293448-A1 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118361-A1 | NOVEL POLYMER PARTICLES AND USE THEREOF | PA2G4, EPB41, RPS4X | SMN1; SMN2 2229/4885ALDH1A1 2900/4885TDP1 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.